Cargando…

Computational-based drug repurposing methods in COVID-19

[Image: see text] COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost c...

Descripción completa

Detalles Bibliográficos
Autor principal: Masoudi-Sobhanzadeh, Yosef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416005/
https://www.ncbi.nlm.nih.gov/pubmed/32793443
http://dx.doi.org/10.34172/bi.2020.25
Descripción
Sumario:[Image: see text] COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.